Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxc9
|
ENSMUSG00000036139.6 | homeobox C9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102977788_102977984 | Hoxc9 | 854 | 0.353191 | 0.87 | 7.8e-18 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_107545831_107546264 | 32.62 |
Ubl4b |
ubiquitin-like 4B |
9026 |
0.16 |
chr7_36016982_36017455 | 30.31 |
Gm38991 |
predicted gene, 38991 |
80160 |
0.09 |
chr11_96341091_96341294 | 29.42 |
Hoxb3 |
homeobox B3 |
247 |
0.75 |
chr14_22783336_22783559 | 29.15 |
Gm7473 |
predicted gene 7473 |
8203 |
0.31 |
chr9_71241633_71241928 | 28.77 |
Aldh1a2 |
aldehyde dehydrogenase family 1, subfamily A2 |
25991 |
0.17 |
chr9_17745693_17745850 | 26.66 |
Gm4977 |
predicted gene 4977 |
13101 |
0.21 |
chr15_103060275_103060598 | 26.43 |
5730585A16Rik |
RIKEN cDNA 5730585A16 gene |
1130 |
0.32 |
chr14_16901849_16902015 | 24.86 |
Tpi-rs9 |
triosephosphate isomerase related sequence 9 |
44727 |
0.16 |
chr2_95210339_95210490 | 24.59 |
Gm13794 |
predicted gene 13794 |
183828 |
0.03 |
chr15_20837074_20837310 | 24.45 |
Gm25711 |
predicted gene, 25711 |
71680 |
0.11 |
chr6_52175357_52175664 | 23.88 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
275 |
0.7 |
chr6_52177007_52177198 | 23.38 |
5730596B20Rik |
RIKEN cDNA 5730596B20 gene |
396 |
0.56 |
chr11_96333479_96333781 | 22.27 |
Hoxb3 |
homeobox B3 |
5568 |
0.08 |
chr1_62851364_62851539 | 21.43 |
Gm4208 |
predicted gene 4208 |
19081 |
0.19 |
chr13_71270446_71270667 | 21.27 |
Mir466f-4 |
microRNA 466f-4 |
163467 |
0.04 |
chr6_29066398_29066549 | 20.04 |
Lep |
leptin |
1011 |
0.51 |
chr14_21891851_21892045 | 19.86 |
4931407E12Rik |
RIKEN cDNA 4931407E12 gene |
2182 |
0.25 |
chr15_35774951_35775110 | 19.81 |
9130002K18Rik |
RIKEN cDNA 9130002K18 gene |
12124 |
0.18 |
chr13_37492137_37492574 | 19.76 |
Gm47732 |
predicted gene, 47732 |
9970 |
0.1 |
chr15_103061553_103061747 | 19.49 |
5730585A16Rik |
RIKEN cDNA 5730585A16 gene |
2344 |
0.16 |
chr18_69794501_69794849 | 19.39 |
Tcf4 |
transcription factor 4 |
112295 |
0.06 |
chr7_24391143_24391359 | 18.86 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
8197 |
0.09 |
chr12_49107545_49107701 | 18.86 |
Gm7456 |
predicted gene 7456 |
32633 |
0.22 |
chr17_54158879_54159048 | 18.30 |
Gm37966 |
predicted gene, 37966 |
64550 |
0.11 |
chr12_81166185_81166336 | 18.28 |
Mir3067 |
microRNA 3067 |
109 |
0.97 |
chr6_36890255_36890607 | 18.17 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
46617 |
0.15 |
chr6_52213227_52213582 | 18.15 |
Gm28308 |
predicted gene 28308 |
65 |
0.48 |
chr11_47188652_47188809 | 18.02 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
190792 |
0.03 |
chr11_57837001_57837152 | 18.00 |
Hand1 |
heart and neural crest derivatives expressed 1 |
4258 |
0.18 |
chr15_103032811_103032985 | 17.68 |
Hoxc4 |
homeobox C4 |
1497 |
0.22 |
chr17_83222582_83223174 | 17.13 |
Pkdcc |
protein kinase domain containing, cytoplasmic |
1843 |
0.39 |
chr6_52161197_52161390 | 17.12 |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
2769 |
0.08 |
chr6_117407303_117407454 | 17.09 |
Gm4640 |
predicted gene 4640 |
16239 |
0.22 |
chr10_120433281_120433486 | 17.02 |
Mir763 |
microRNA 763 |
14727 |
0.17 |
chr14_117419849_117420000 | 16.80 |
Gpc6 |
glypican 6 |
493988 |
0.0 |
chr11_96270905_96271430 | 16.74 |
Hoxb9 |
homeobox B9 |
290 |
0.76 |
chr10_120421038_120421369 | 16.68 |
Mir763 |
microRNA 763 |
26907 |
0.14 |
chr11_18357336_18357543 | 16.67 |
Gm12020 |
predicted gene 12020 |
29768 |
0.21 |
chr18_70697879_70698218 | 16.61 |
Gm50261 |
predicted gene, 50261 |
8449 |
0.22 |
chr15_37433241_37433480 | 16.43 |
Gm15941 |
predicted gene 15941 |
54 |
0.96 |
chr8_26622757_26623107 | 16.41 |
Gm32050 |
predicted gene, 32050 |
4548 |
0.19 |
chr3_37906780_37907292 | 16.32 |
Gm20755 |
predicted gene, 20755 |
8223 |
0.18 |
chr2_24553985_24554315 | 16.15 |
Gm13417 |
predicted gene 13417 |
12547 |
0.14 |
chr17_27294305_27294456 | 16.06 |
Mir7214 |
microRNA 7214 |
22715 |
0.08 |
chr8_26594087_26594265 | 15.92 |
Gm39149 |
predicted gene, 39149 |
14374 |
0.17 |
chr6_63963910_63964072 | 15.49 |
Gm44072 |
predicted gene, 44072 |
77566 |
0.11 |
chr2_74741432_74741583 | 15.32 |
Hoxd3 |
homeobox D3 |
1888 |
0.12 |
chr7_72990908_72991250 | 15.31 |
Gm5335 |
predicted gene 5335 |
926 |
0.67 |
chr1_178590641_178590838 | 14.82 |
Gm24405 |
predicted gene, 24405 |
46166 |
0.15 |
chr13_71270674_71270825 | 14.51 |
Mir466f-4 |
microRNA 466f-4 |
163660 |
0.04 |
chr12_54214286_54214606 | 14.49 |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
10586 |
0.15 |
chr8_120392033_120392269 | 14.31 |
Gm22715 |
predicted gene, 22715 |
51398 |
0.12 |
chr2_74698677_74699049 | 14.30 |
Hoxd9 |
homeobox D9 |
1136 |
0.16 |
chr3_31212610_31212773 | 14.09 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
45703 |
0.14 |
chr4_47870753_47870904 | 14.03 |
Gm22670 |
predicted gene, 22670 |
49927 |
0.15 |
chr8_23404325_23404476 | 13.94 |
Sfrp1 |
secreted frizzled-related protein 1 |
7102 |
0.26 |
chr11_112885632_112885789 | 13.77 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
60531 |
0.13 |
chr9_67116044_67116314 | 13.74 |
Gm22145 |
predicted gene, 22145 |
11971 |
0.16 |
chr4_98106960_98107306 | 13.69 |
Gm12691 |
predicted gene 12691 |
39466 |
0.19 |
chr5_91727647_91727798 | 13.55 |
Trmt112-ps1 |
tRNA methyltransferase 11-2, pseudogene 1 |
10357 |
0.15 |
chr14_120102834_120102993 | 13.51 |
Gm20167 |
predicted gene, 20167 |
25403 |
0.16 |
chr10_97220509_97220676 | 13.42 |
Gm8613 |
predicted gene 8613 |
20222 |
0.2 |
chr1_152973075_152973294 | 13.36 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
17910 |
0.15 |
chr4_106092065_106092511 | 13.33 |
Gm12727 |
predicted gene 12727 |
6636 |
0.18 |
chr5_89147272_89147624 | 13.32 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
119356 |
0.06 |
chr5_45572932_45573083 | 13.28 |
Gm42520 |
predicted gene 42520 |
16327 |
0.12 |
chr18_11967118_11967331 | 13.07 |
Gm49968 |
predicted gene, 49968 |
54093 |
0.13 |
chr3_105538840_105539458 | 13.02 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr2_59404104_59404255 | 12.98 |
Gm13549 |
predicted gene 13549 |
4398 |
0.2 |
chr11_76659259_76659410 | 12.85 |
Bhlha9 |
basic helix-loop-helix family, member a9 |
13136 |
0.17 |
chr1_44580407_44580702 | 12.81 |
Gm37626 |
predicted gene, 37626 |
19669 |
0.19 |
chr8_32069341_32069519 | 12.72 |
Nrg1 |
neuregulin 1 |
59889 |
0.15 |
chr2_165195489_165196220 | 12.69 |
Cdh22 |
cadherin 22 |
14395 |
0.16 |
chr10_91436281_91436578 | 12.67 |
Gm47084 |
predicted gene, 47084 |
11951 |
0.22 |
chr4_107590853_107591501 | 12.64 |
Glis1 |
GLIS family zinc finger 1 |
9974 |
0.2 |
chr9_111535536_111535702 | 12.54 |
Gm42523 |
predicted gene 42523 |
13321 |
0.19 |
chr1_178707893_178708077 | 12.39 |
Gm34176 |
predicted gene, 34176 |
47823 |
0.15 |
chr4_117330921_117331072 | 12.37 |
Rnf220 |
ring finger protein 220 |
30968 |
0.11 |
chr12_87369451_87369606 | 12.25 |
Gm48806 |
predicted gene, 48806 |
2464 |
0.15 |
chr3_121713445_121713648 | 12.11 |
Gm43607 |
predicted gene 43607 |
1118 |
0.33 |
chr12_26759066_26759251 | 12.10 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
75701 |
0.11 |
chr9_77427357_77427508 | 12.05 |
Lrrc1 |
leucine rich repeat containing 1 |
14763 |
0.17 |
chr2_74747203_74747372 | 12.05 |
Hoxd3 |
homeobox D3 |
1565 |
0.15 |
chr6_40778516_40778778 | 12.03 |
Mgam2-ps |
maltase-glucoamylase 2, pseudogene |
64 |
0.97 |
chr16_57484144_57484357 | 12.03 |
Filip1l |
filamin A interacting protein 1-like |
64992 |
0.11 |
chr8_33139056_33139207 | 12.02 |
Gm6877 |
predicted pseudogene 6877 |
53165 |
0.15 |
chr16_21277873_21278062 | 11.99 |
Gm16863 |
predicted gene, 16863 |
18905 |
0.14 |
chr13_72210578_72210729 | 11.91 |
Gm4052 |
predicted gene 4052 |
139568 |
0.05 |
chr9_27937707_27937883 | 11.83 |
Opcml |
opioid binding protein/cell adhesion molecule-like |
146493 |
0.05 |
chr3_138500004_138500207 | 11.79 |
Gm43724 |
predicted gene 43724 |
4012 |
0.13 |
chr18_32038238_32038389 | 11.75 |
Myo7b |
myosin VIIB |
1352 |
0.32 |
chr7_130335549_130335738 | 11.72 |
Gm5903 |
predicted gene 5903 |
18719 |
0.22 |
chr15_25803235_25803388 | 11.61 |
Myo10 |
myosin X |
23121 |
0.18 |
chr11_96318827_96319554 | 11.60 |
Hoxb4 |
homeobox B4 |
923 |
0.28 |
chr13_92042121_92042511 | 11.52 |
Rasgrf2 |
RAS protein-specific guanine nucleotide-releasing factor 2 |
11412 |
0.28 |
chr13_63951981_63952425 | 11.49 |
Gm7695 |
predicted gene 7695 |
5682 |
0.22 |
chr5_22196608_22196786 | 11.40 |
Reln |
reelin |
62028 |
0.11 |
chr10_92162409_92163019 | 11.38 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr18_83185182_83185655 | 11.35 |
1700095A13Rik |
RIKEN cDNA 1700095A13 gene |
77528 |
0.09 |
chr7_58842804_58843216 | 11.34 |
Gm6226 |
predicted gene 6226 |
5072 |
0.21 |
chr12_45670310_45670571 | 11.18 |
Gm48518 |
predicted gene, 48518 |
1353 |
0.55 |
chr2_74721927_74722168 | 11.08 |
Hoxd4 |
homeobox D4 |
69 |
0.9 |
chr9_29318648_29319159 | 11.04 |
Ntm |
neurotrimin |
92833 |
0.1 |
chr2_69629165_69629480 | 11.02 |
Bbs5 |
Bardet-Biedl syndrome 5 (human) |
17849 |
0.16 |
chr17_27207171_27207322 | 10.98 |
Lemd2 |
LEM domain containing 2 |
2777 |
0.14 |
chr7_84237857_84238008 | 10.89 |
Gm44827 |
predicted gene 44827 |
5013 |
0.17 |
chr12_33030107_33030284 | 10.86 |
Cdhr3 |
cadherin-related family member 3 |
22791 |
0.13 |
chr2_144837421_144837575 | 10.81 |
Scp2d1 |
SCP2 sterol-binding domain containing 1 |
13842 |
0.23 |
chr6_66382723_66382897 | 10.80 |
Gm44281 |
predicted gene, 44281 |
15906 |
0.17 |
chr4_19718959_19719110 | 10.62 |
Gm12354 |
predicted gene 12354 |
852 |
0.65 |
chr5_113448375_113448559 | 10.61 |
Wscd2 |
WSC domain containing 2 |
41866 |
0.14 |
chr9_60501613_60501977 | 10.55 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
4669 |
0.17 |
chr16_18156713_18156920 | 10.53 |
Mir6366 |
microRNA 6366 |
8354 |
0.12 |
chr18_35926947_35927401 | 10.50 |
Gm50405 |
predicted gene, 50405 |
3879 |
0.14 |
chr10_8213987_8214315 | 10.39 |
Gm30906 |
predicted gene, 30906 |
38020 |
0.2 |
chr7_75296761_75296912 | 10.38 |
Sv2b |
synaptic vesicle glycoprotein 2 b |
11473 |
0.2 |
chr3_54358528_54358730 | 10.35 |
Postn |
periostin, osteoblast specific factor |
2480 |
0.4 |
chr13_24620418_24620826 | 10.34 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
5995 |
0.21 |
chr11_35278289_35278716 | 10.33 |
Gm12123 |
predicted gene 12123 |
45168 |
0.15 |
chr5_46083391_46083556 | 10.30 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
151064 |
0.04 |
chr4_137142421_137142770 | 10.25 |
Gm13003 |
predicted gene 13003 |
22471 |
0.11 |
chr6_84306718_84306912 | 10.25 |
Gm44127 |
predicted gene, 44127 |
81563 |
0.09 |
chr5_67223044_67223221 | 10.04 |
Tmem33 |
transmembrane protein 33 |
37433 |
0.13 |
chr11_18883607_18883779 | 10.01 |
Gm37818 |
predicted gene, 37818 |
4098 |
0.19 |
chr1_24286477_24286690 | 10.01 |
Col9a1 |
collagen, type IX, alpha 1 |
57066 |
0.14 |
chr14_70659174_70659883 | 10.00 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr5_37196797_37196948 | 9.95 |
Gm1043 |
predicted gene 1043 |
10975 |
0.19 |
chr12_15698585_15698756 | 9.95 |
Gm4804 |
predicted gene 4804 |
18930 |
0.23 |
chr12_69782272_69782577 | 9.93 |
4930512B01Rik |
RIKEN cDNA 4930512B01 gene |
7864 |
0.12 |
chr2_14801553_14801705 | 9.90 |
Gm13316 |
predicted gene 13316 |
10909 |
0.14 |
chr15_63750322_63750611 | 9.89 |
Gm49019 |
predicted gene, 49019 |
1193 |
0.34 |
chr18_60513221_60513372 | 9.88 |
Smim3 |
small integral membrane protein 3 |
11309 |
0.15 |
chr9_109107438_109107595 | 9.86 |
Plxnb1 |
plexin B1 |
722 |
0.49 |
chr2_105132350_105132533 | 9.81 |
Wt1 |
Wilms tumor 1 homolog |
1558 |
0.37 |
chr12_102597538_102597806 | 9.79 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
3595 |
0.17 |
chr13_32080651_32080802 | 9.77 |
Gm48885 |
predicted gene, 48885 |
18449 |
0.25 |
chr5_131722817_131723110 | 9.76 |
Gm42442 |
predicted gene 42442 |
24610 |
0.15 |
chr18_57386430_57386725 | 9.75 |
Prrc1 |
proline-rich coiled-coil 1 |
5776 |
0.19 |
chr9_49962580_49962754 | 9.74 |
Gm47543 |
predicted gene, 47543 |
7789 |
0.29 |
chr18_78339971_78340124 | 9.69 |
Gm6133 |
predicted gene 6133 |
9707 |
0.29 |
chr4_120232123_120232330 | 9.67 |
Foxo6 |
forkhead box O6 |
55123 |
0.12 |
chr2_173171192_173172247 | 9.65 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
18637 |
0.15 |
chr1_178728377_178728528 | 9.62 |
Gm34176 |
predicted gene, 34176 |
27356 |
0.21 |
chr8_121346202_121346502 | 9.61 |
Gm26815 |
predicted gene, 26815 |
10484 |
0.21 |
chr5_30974950_30975153 | 9.59 |
Tcf23 |
transcription factor 23 |
6389 |
0.1 |
chr4_97839557_97839811 | 9.58 |
Nfia |
nuclear factor I/A |
40435 |
0.18 |
chr17_47966111_47966262 | 9.56 |
Gm5228 |
predicted gene 5228 |
30096 |
0.11 |
chr14_21988647_21988815 | 9.56 |
Zfp503 |
zinc finger protein 503 |
870 |
0.51 |
chr15_103168770_103169277 | 9.53 |
Smug1 |
single-strand selective monofunctional uracil DNA glycosylase |
1931 |
0.21 |
chr18_12503881_12504205 | 9.51 |
Lama3 |
laminin, alpha 3 |
156 |
0.75 |
chr1_42472959_42473146 | 9.49 |
Gm37047 |
predicted gene, 37047 |
18761 |
0.24 |
chr4_114605752_114605926 | 9.47 |
Gm28864 |
predicted gene 28864 |
67501 |
0.11 |
chr2_115869083_115869502 | 9.45 |
Meis2 |
Meis homeobox 2 |
425 |
0.91 |
chr4_111357263_111357461 | 9.44 |
Gm12805 |
predicted gene 12805 |
36757 |
0.17 |
chr16_43931567_43931842 | 9.40 |
Qtrt2 |
queuine tRNA-ribosyltransferase accessory subunit 2 |
4895 |
0.17 |
chr7_98956814_98956965 | 9.34 |
Uvrag |
UV radiation resistance associated gene |
12984 |
0.16 |
chr11_36832942_36833149 | 9.32 |
Gm22127 |
predicted gene, 22127 |
110163 |
0.07 |
chr4_151367052_151367207 | 9.29 |
4930589P08Rik |
RIKEN cDNA 4930589P08 gene |
9341 |
0.3 |
chr2_106694777_106694944 | 9.27 |
Mpped2 |
metallophosphoesterase domain containing 2 |
360 |
0.9 |
chr6_50819294_50819486 | 9.27 |
Gm44109 |
predicted gene, 44109 |
16359 |
0.15 |
chr14_19738470_19738798 | 9.22 |
Nid2 |
nidogen 2 |
12631 |
0.15 |
chr6_84272990_84273178 | 9.17 |
Gm44127 |
predicted gene, 44127 |
47832 |
0.15 |
chr17_85747989_85748270 | 9.16 |
CJ186046Rik |
Riken cDNA CJ186046 gene |
54500 |
0.12 |
chr9_59189335_59189486 | 9.15 |
Gm7589 |
predicted gene 7589 |
43200 |
0.15 |
chr10_30280095_30280246 | 9.11 |
Cenpw |
centromere protein W |
79610 |
0.09 |
chr18_22338923_22339083 | 9.07 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
5243 |
0.35 |
chr6_84102016_84102167 | 9.05 |
Dysf |
dysferlin |
3282 |
0.23 |
chr11_22636910_22637072 | 9.01 |
Gm12053 |
predicted gene 12053 |
10327 |
0.19 |
chr4_148399461_148399754 | 9.00 |
Gm13200 |
predicted gene 13200 |
40147 |
0.1 |
chr14_96218177_96218332 | 8.97 |
Gm15515 |
predicted gene 15515 |
13699 |
0.3 |
chr5_102768408_102768711 | 8.94 |
Arhgap24 |
Rho GTPase activating protein 24 |
212 |
0.97 |
chr1_162346730_162346881 | 8.84 |
Gm16101 |
predicted gene 16101 |
30713 |
0.16 |
chr6_89012844_89013032 | 8.81 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
62255 |
0.09 |
chr1_129837836_129838016 | 8.80 |
Gm37479 |
predicted gene, 37479 |
4778 |
0.2 |
chr12_8856328_8856551 | 8.80 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
20943 |
0.17 |
chr11_120225560_120225728 | 8.78 |
2900052L18Rik |
RIKEN cDNA 2900052L18 gene |
5941 |
0.1 |
chr11_8781304_8781710 | 8.75 |
Gm11990 |
predicted gene 11990 |
25341 |
0.22 |
chr1_194714751_194714909 | 8.75 |
2900035J10Rik |
RIKEN cDNA 2900035J10 gene |
17877 |
0.16 |
chr5_17648843_17649193 | 8.73 |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
45184 |
0.19 |
chr4_124950807_124950994 | 8.68 |
9930104L06Rik |
RIKEN cDNA 9930104L06 gene |
7769 |
0.11 |
chr4_27887710_27887861 | 8.68 |
Gm11914 |
predicted gene 11914 |
20130 |
0.27 |
chr6_107375452_107375609 | 8.67 |
Gm44399 |
predicted gene, 44399 |
29529 |
0.2 |
chr4_128087799_128087981 | 8.66 |
Csmd2os |
CUB and Sushi multiple domains 2, opposite strand |
76369 |
0.1 |
chr6_148367214_148367365 | 8.65 |
Gm44021 |
predicted gene, 44021 |
2633 |
0.22 |
chr15_70988316_70988478 | 8.65 |
Gm49430 |
predicted gene, 49430 |
25933 |
0.26 |
chr7_6727792_6729098 | 8.65 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr15_83666603_83666754 | 8.60 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
6198 |
0.22 |
chr5_99099914_99100068 | 8.60 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
62640 |
0.11 |
chr8_35224113_35224448 | 8.57 |
Gm34533 |
predicted gene, 34533 |
1322 |
0.37 |
chr3_62348500_62348904 | 8.56 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr15_42373080_42373231 | 8.51 |
Gm49453 |
predicted gene, 49453 |
26600 |
0.18 |
chr15_93062899_93063085 | 8.50 |
Gm18685 |
predicted gene, 18685 |
26238 |
0.19 |
chr15_33196938_33197210 | 8.50 |
Cpq |
carboxypeptidase Q |
106766 |
0.07 |
chr6_148194402_148194561 | 8.48 |
Ergic2 |
ERGIC and golgi 2 |
760 |
0.63 |
chr16_6769633_6769784 | 8.45 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
39514 |
0.24 |
chr6_141014975_141015345 | 8.45 |
Gm43927 |
predicted gene, 43927 |
6875 |
0.27 |
chr11_8761743_8761940 | 8.45 |
Gm11990 |
predicted gene 11990 |
45007 |
0.17 |
chr2_166237976_166238138 | 8.44 |
Gm11467 |
predicted gene 11467 |
29430 |
0.14 |
chr14_16733560_16733930 | 8.43 |
Rarb |
retinoic acid receptor, beta |
85260 |
0.1 |
chr1_38545629_38545887 | 8.42 |
Gm34727 |
predicted gene, 34727 |
58239 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.1 | 44.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.6 | 10.8 | GO:0006868 | glutamine transport(GO:0006868) |
2.2 | 8.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.2 | 8.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.1 | 8.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
2.1 | 6.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.8 | 5.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.8 | 7.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.8 | 5.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.8 | 8.9 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 7.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.7 | 5.0 | GO:0035799 | ureter maturation(GO:0035799) |
1.4 | 4.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 4.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.4 | 4.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.4 | 5.5 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
1.3 | 4.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.3 | 9.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.3 | 10.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 5.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.2 | 3.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 7.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.2 | 4.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 1.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.1 | 1.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.1 | 4.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.1 | 3.2 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.1 | 2.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
1.0 | 1.9 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.8 | 2.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.8 | 6.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 2.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 2.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.8 | 4.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 4.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 5.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 3.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.8 | 0.8 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.7 | 3.0 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.7 | 2.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 10.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.7 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 0.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.7 | 2.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.7 | 0.7 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.7 | 2.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 2.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.7 | 3.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.7 | 1.3 | GO:0048793 | pronephros development(GO:0048793) |
0.7 | 2.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 2.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 3.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.6 | 1.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 1.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.6 | 4.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.6 | 3.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 3.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 2.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 67.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.6 | 1.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 2.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 3.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 2.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.5 | 1.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 2.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.5 | 2.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.5 | 1.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 1.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 0.5 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.5 | 1.4 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 2.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 1.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 2.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 0.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 0.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.4 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 2.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 3.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 2.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 1.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.4 | GO:0071046 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.4 | 2.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 2.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 0.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.4 | 1.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 0.8 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 1.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.4 | 3.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 1.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 1.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.3 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.3 | 1.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 1.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 1.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 1.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 3.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 1.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 1.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 0.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 1.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 2.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.3 | 1.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.3 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 2.0 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 2.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.7 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 1.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 3.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 4.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.3 | 1.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 2.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 0.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.8 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.3 | GO:0038086 | cell migration involved in vasculogenesis(GO:0035441) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.5 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 0.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 1.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.2 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.2 | 0.7 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.2 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 3.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.9 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.2 | 2.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 3.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 1.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 1.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 2.3 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 1.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 1.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.4 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.2 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 1.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 1.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.4 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 3.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 1.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.9 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.4 | GO:1900625 | monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 1.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.3 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 1.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 1.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 2.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 1.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.3 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 4.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.3 | GO:1904746 | negative regulation of apoptotic process involved in development(GO:1904746) |
0.2 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.7 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.3 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.1 | 1.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.1 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 6.7 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 1.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.1 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 2.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.3 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 1.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 2.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 1.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.7 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 1.3 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 1.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.5 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 1.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 2.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 1.0 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 1.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.7 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 1.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 7.8 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.1 | 0.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.6 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 1.0 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 1.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 2.8 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 2.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.7 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.2 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 7.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0060374 | mast cell differentiation(GO:0060374) regulation of mast cell differentiation(GO:0060375) |
0.1 | 1.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 2.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 2.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 3.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.6 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 0.8 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 8.2 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.1 | 4.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 4.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 3.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0044319 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 1.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.1 | 0.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.7 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 2.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.1 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 1.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.1 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.1 | 0.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 1.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0044532 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.1 | 6.5 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.9 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 1.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.0 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.0 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.2 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 1.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0070662 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.8 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 1.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.8 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 1.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 2.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.0 | 0.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.7 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.3 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.4 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.1 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.0 | 0.0 | GO:0006971 | hypotonic response(GO:0006971) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.3 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.3 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.4 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.0 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:2000286 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.2 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.3 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.0 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.9 | GO:0060541 | respiratory system development(GO:0060541) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.1 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.5 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.7 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.5 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.0 | 0.4 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.7 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:0072537 | fibroblast activation(GO:0072537) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.0 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.2 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0060675 | ureteric bud morphogenesis(GO:0060675) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0055123 | digestive system development(GO:0055123) |
0.0 | 0.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.0 | 0.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 2.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 3.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 2.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 3.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 6.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 1.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 4.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 11.5 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 5.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 1.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 11.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 5.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.1 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.7 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.9 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 4.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 13.6 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.4 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.4 | GO:0043256 | laminin complex(GO:0043256) |
0.2 | 1.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 2.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 9.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 10.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.7 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 2.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.5 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 2.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 3.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 12.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 2.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 3.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.8 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 2.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 9.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 5.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 4.0 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 3.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 5.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 4.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 6.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.5 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 10.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 2.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 12.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 2.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.4 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.4 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 1.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 2.9 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 1.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 3.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.6 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 11.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.0 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 14.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 3.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.1 | 4.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.1 | 3.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 3.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 19.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.8 | 2.5 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.8 | 2.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 3.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 3.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.7 | 2.1 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 2.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.7 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 3.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 4.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 1.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 10.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 6.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 1.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.5 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 4.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 28.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 1.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 5.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 1.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 7.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 1.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 2.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 0.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 3.4 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 3.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 1.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 10.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 2.2 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 3.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 2.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 5.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 3.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 3.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 4.4 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.2 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 12.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 10.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.7 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 2.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 2.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 2.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 127.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 4.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.8 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.6 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 3.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 1.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 5.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 3.2 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.9 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 3.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 1.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 1.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.5 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 1.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 11.1 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 19.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 3.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.4 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 3.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 3.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 1.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 1.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 2.7 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 1.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 2.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 2.3 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 10.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 2.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.3 | GO:0018651 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 12.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 1.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 1.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 4.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 2.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 2.9 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.7 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 2.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 1.3 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 12.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 2.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 1.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.4 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.8 | GO:0080032 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.0 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.0 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0052773 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.0 | 0.1 | GO:0099528 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 1.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.0 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 8.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 5.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 13.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 9.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 3.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 5.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 5.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 5.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 5.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 5.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 4.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 6.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 22.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 5.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 4.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 7.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 11.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 3.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 10.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 4.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 5.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 10.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 9.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 5.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 3.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 2.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 2.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 10.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 1.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 4.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 7.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 12.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 2.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.7 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 4.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 13.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 3.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 4.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 5.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 2.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 2.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |